THE RELATION BETWEEN PLASMA NT-proBNP LEVELS AND SOME CLINICAL, SUBCLINICAL CHARACTERISTICS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Main Article Content
Abstract
Objectives: To investigate the relation between plasma NT-proBNP levels at admission with some clinical, subclinical characteristics in patients with acute myocardial infarction. Subjects and methods: A prospective, descriptive and cross-sectional study was conducted on 57 patients with acute myocardial infarction, treated in Cardiovascular Center of Military Hospital 103, from September 2019 to May 2020. The patients underwent clinical examination, laboratory tests, ECG, echocardiography, coronary angiogram and were tested plasma NT-proBNP levels at admission. Results: Mean NT-proBNP levels was 1681,5 ±3846,8 pg/ml, median value was 293,7 pg/ml. There was no difference in NT-proBNP levels in patients with STEMI and NSTEMI. NT-proBNP levels had a close positive correlation with age (r=0,5, p<0,01), a close positive correlation with Troponin I levels (r=0,5, p<0,01), a slight positive correlation with CK-MB levels (r=0,2, p<0,01) and a moderate correlation with GRACE score (r=0,346, p<0,01). There was no difference in NT-proBNP levels in patients with different culprit coronary arteries. Conclusion: Plasma NT-proBNP levels in patients with acute myocardial infarction had a close positive correlation with ages and Troponin I levels, a moderate correlation with GRACE score and a slight positive correlation with CK-MB levels.
Article Details
References
2. He Wf., Jiang L., Chen Yy., et al (2021), " The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study", BMC Cardiovasc Disord 21, 202.
3. Shirley Siang Ning T., Keng Tat K., Alan Yean Yip F., et al (2022), “NT-proBNP Cut-off Values for Risk Stratification in Acute MI and Comparison with Other Risk Assessment Scores”, Journal of Asian Pacific Society of Cardiology;1:e10.
4. Schellings DA., Adiyaman A., Dambrink JE., et al (2016), “Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores”, Vasc Health Risk Manag;12: pp 471-476.
5. Allan S J., Kristian T., Joseph S A., et al. (2018), “Fourth universal definition of myocardial infarction”, European Heart Journal, Volume 40, Issue 3, 14 January 2019, Pages 237–269.
6. Salama RH., El-Moniem AE., El-Hefney N., Samor T. (2011), “N-TerminaL PRO-BNP in Acute Coronary Syndrome Patients with ST Elevation Versus Non ST Elevation in Qassim Region of Saudi Arabia’’, Int J Health Sci (Qassim);5(2), pp 136-145.
7. Galvani M., Ottani F., Oltrona L., et al. (2004), "N-Terminal Pro-Brain Natriuretic Peptide on Admission Has Prognostic Value Across the Whole Spectrum of Acute Coronary Syndromes", Circulation, 110, pp.128-134
8. Nguyễn Thị Hồng Huệ (2013), "Nghiên cứu giá trị NT - proBNP trong tiên lượng ngắn hạn nhồi máu cơ tim cấp không ST chênh lên", Tạp chí Y học Thực hành, số 6 (872), tr.68-73.